CID 15956308

Schembl6955403

Structural Information

Molecular Formula
C19H22N6O2
SMILES
CCN1C2=C(C=CC=N2)N(C(=O)C3=C1N=CC(=C3)CCC4=CN(NO4)C)C
InChI
InChI=1S/C19H22N6O2/c1-4-25-17-15(19(26)24(3)16-6-5-9-20-18(16)25)10-13(11-21-17)7-8-14-12-23(2)22-27-14/h5-6,9-12,22H,4,7-8H2,1-3H3
InChIKey
BDYDKJSQGIQQQZ-UHFFFAOYSA-N
Compound name
2-ethyl-9-methyl-13-[2-(3-methyl-2H-oxadiazol-5-yl)ethyl]-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-10-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

4
Patents

366.18042 Da
Monoisotopic Mass

2.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 367.18770 194.2
[M+Na]+ 389.16964 204.2
[M-H]- 365.17314 196.3
[M+NH4]+ 384.21424 200.4
[M+K]+ 405.14358 201.2
[M+H-H2O]+ 349.17768 180.9
[M+HCOO]- 411.17862 204.1
[M+CH3COO]- 425.19427 201.7
[M+Na-2H]- 387.15509 194.6
[M]+ 366.17987 193.5
[M]- 366.18097 193.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe